𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The influence of traffic-related pollution on individuals' life-style: results from the BRFSS

✍ Scribed by Cinzia Di Novi


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
247 KB
Volume
19
Category
Article
ISSN
1057-9230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This paper employs the Behavioral Risk Factor Surveillance System (2001) data in conjunction with the Environmental Protection Agency's Air Quality System data to investigate how air pollution caused by motor vehicle emissions affects the likelihood of good health and the amount of health investments. Models are estimated using three different measures of overall health: a measure of self‐assessed health and two health outcome indicators (asthma and blood pressure). A multivariate probit approach is used to estimate recursive systems of equations for self‐assessed health, health outcomes and life‐styles. The most interesting result concerns the influence of pollution on health‐improving life‐style choices: only if traffic pollution is in the ‘satisfactory range’ (AQI level at or below 100), individuals will have incentive to invest in health. Copyright © 2009 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


The influence of vascular space involvem
✍ Andreas Obermair; Christian Wanner; Selcuk Bilgi; Paul Speiser; Klaus Reisenberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 1 views

staining from the same block in two separate runs. cology and Obstetrics, University Hospital of Vi- ## RESULTS. The median follow-up period was 85 months (range, 5-170 months). enna, Vienna, Austria. The 25% quantile for OS was 109 months (median not reached; range, 5-170 2 Division of Obstetric

Impact of oral cyclophosphamide on healt
✍ Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC